SE9302013D0 - Foerfarande foer bestaemning av hba 1c och komposition foer genomfoerandet av foerfarandet - Google Patents

Foerfarande foer bestaemning av hba 1c och komposition foer genomfoerandet av foerfarandet

Info

Publication number
SE9302013D0
SE9302013D0 SE9302013A SE9302013A SE9302013D0 SE 9302013 D0 SE9302013 D0 SE 9302013D0 SE 9302013 A SE9302013 A SE 9302013A SE 9302013 A SE9302013 A SE 9302013A SE 9302013 D0 SE9302013 D0 SE 9302013D0
Authority
SE
Sweden
Prior art keywords
procedure
hba
determination
composition before
before implementation
Prior art date
Application number
SE9302013A
Other languages
English (en)
Other versions
SE9302013L (sv
SE504914C2 (sv
Inventor
O *Jeppsson Jan
Original Assignee
Boehringer Mannheim Scandinavia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Scandinavia Ab filed Critical Boehringer Mannheim Scandinavia Ab
Priority to SE9302013A priority Critical patent/SE504914C2/sv
Publication of SE9302013D0 publication Critical patent/SE9302013D0/sv
Priority to AU70123/94A priority patent/AU7012394A/en
Priority to PCT/SE1994/000564 priority patent/WO1994029730A1/en
Publication of SE9302013L publication Critical patent/SE9302013L/sv
Publication of SE504914C2 publication Critical patent/SE504914C2/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE9302013A 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet SE504914C2 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (sv) 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet
AU70123/94A AU7012394A (en) 1993-06-11 1994-06-10 Method for determining hba1c, and composition for implementing the method
PCT/SE1994/000564 WO1994029730A1 (en) 1993-06-11 1994-06-10 METHOD FOR DETERMINING HbA1c, AND COMPOSITION FOR IMPLEMENTING THE METHOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (sv) 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet

Publications (3)

Publication Number Publication Date
SE9302013D0 true SE9302013D0 (sv) 1993-06-11
SE9302013L SE9302013L (sv) 1994-12-12
SE504914C2 SE504914C2 (sv) 1997-05-26

Family

ID=20390247

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302013A SE504914C2 (sv) 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet

Country Status (3)

Country Link
AU (1) AU7012394A (sv)
SE (1) SE504914C2 (sv)
WO (1) WO1994029730A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE444491T1 (de) 2005-05-20 2009-10-15 Germediq Forsch & Entw Ges Mbh Verfahren zur bestimmung von kardiovaskulären risikofaktoren
CN106033076A (zh) * 2015-03-18 2016-10-19 杭州量康科技有限公司 用于检测干血样本的方法以及系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments

Also Published As

Publication number Publication date
AU7012394A (en) 1995-01-03
SE9302013L (sv) 1994-12-12
SE504914C2 (sv) 1997-05-26
WO1994029730A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
DE69434497D1 (de) Verwendung von alpha-1,4-glukanlyase zur herstellung von 1,5 d-anhydrofruktose
NO982055L (no) 2-alkylpyrrolidiner
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
EA199900725A1 (ru) Синергетические комбинации сульфонилмочевины и глитазона при лечении диабета
DK97189A (da) Immobiliseringsproces
BR9306683A (pt) Adesivo proteináceo curado com aldeído
BR9507690A (pt) Detecção de reticulócitos
DK502189A (da) Forbedringer ved eller vedroerende antistoffer
DK322188D0 (da) Fremgangsmaade til fremstilling af protein
NO951740D0 (no) Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse
ES506347A0 (es) Procedimiento de separacion de mezclas biologicas
DK0407813T3 (da) Oxidativ denaturering af proteinanalytter
FI893428A7 (sv) Eliminering av toxiska egenskaper in vitro och in vivo hos TNF-a medelst monoklonala antikroppar och fragment härledda från dessa
PT98193A (pt) Estojo para a dosagem especifica de angiotensina ii
KR840008287A (ko) B형 간염 바이러스 표면항원의 정제방법
SE7904282L (sv) Forfarande for detektering av rispor i provkroppar
KR900005986A (ko) 항원용액중의 보조제로서 수산화아연 또는 수산화철의 용도, 및 이러한 보조제를 함유하는 항원용액
SE9302013L (sv) Förfarande för bestämning av HbA 1C och komposition för genomförandet av förfarandet
ATE37611T1 (de) Verfahren zur verringerung einer truebung in kontrollseren.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
KR890008313A (ko) 안티 pci모노클론 항체
WO2002037093A3 (en) Gel trap for electrophoresis
ES2110998T3 (es) Procedimiento para la determinacion de las trombopenias.
PT1171578E (pt) Composicao farmaceutica compreendendo as celulas nkt activadas pelo pim e sua utilizacao em terapia

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9302013-9

Format of ref document f/p: F